Alimera Sciences, Inc. News Headlines

ALIM 
$5.84
*  
0.11
1.92%
Get ALIM Alerts
*Delayed - data as of Dec. 19, 2014  -  Find a broker to begin trading ALIM now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Alimera Sciences Inks Deal With Deerfield Management For $50.0 Mln Financing
11/28/2014 8:40:00 AM - RTT News


Alimera Announces Marketing Authorization For ILUVIEN In Belgium - Quick Facts
11/12/2014 6:29:00 PM - RTT News


Health Care Sector Update for 11/12/2014: CASI, OCUL, ALIM
11/12/2014 8:34:22 AM - MT Newswires


Alimera Announces Marketing Authorization For ILUVIEN In Brazil - Quick Facts
11/12/2014 7:48:00 AM - RTT News


InsiderInsights.com Daily Round Up 10/1/14: SNTA, AGCO, RSG, DWA
10/2/2014 8:28:00 AM - Seeking Alpha


Alimera/pSivida's Iluvien Receives FDA Approval for DME - Analyst Blog
9/29/2014 4:55:00 PM - Zacks.com


Pre-Market Most Active for Sep 29, 2014 : TIBX, ATHL, BABA, PBR, DWA, TVIX, AAPL, ECYT, JNS, SAN, BP, ALIM
9/29/2014 7:39:56 AM - NASDAQ.com News


AMBI Snapped Up, ALIM''s Iluvien Gets FDA Nod, GLYC Faces Glitch In Study
9/29/2014 2:04:00 AM - RTT News


Alimera: FDA Oks Iluvien As First Long-Term Treatment For Diabetic Macular Edema
9/26/2014 4:23:00 PM - RTT News


2nd Half Of 2014 Biotechnology Catalysts--Part 4
8/17/2014 8:28:00 PM - Seeking Alpha


pSivida: Incredible Upside Potential With Limited Risk
6/9/2014 9:19:00 AM - Seeking Alpha


Alimera/pSivida Seek FDA Approval for Iluvien - Analyst Blog
4/15/2014 3:45:01 PM - Zacks.com


Cramer's Mad Money - 11 Things To Watch In The Week Ahead (3/28/14)
3/30/2014 5:28:00 AM - Seeking Alpha


Ico Therapeutics: Near-Term Catalyst Presents Enormous Upside
2/26/2014 9:01:00 AM - Seeking Alpha


pSivida: Positive Roche And Regeneron Conference Calls Confirm Tehadur's Potential
2/18/2014 8:39:00 AM - Seeking Alpha


Strength Seen in Retrophin (RTRX): Stock Soars 49.8% - Tale of the Tape
2/14/2014 9:04:01 AM - Zacks.com


Zacks #1 Rank Additions for Tuesday - Tale of the Tape
1/28/2014 9:30:01 AM - Zacks.com


Synthetic Biologics (SYN) Slumps: Stock Tanks 11.4% - Tale of the Tape
1/28/2014 8:38:01 AM - Zacks.com


JNJ Beats on Earnings but Guides Below - Analyst Blog
1/21/2014 10:06:01 AM - Zacks.com


Alimera Sciences (ALIM) Jumps: Stock Up 7.5% - Tale of the Tape
1/16/2014 8:51:01 AM - Zacks.com


Zacks #1 Rank Additions for Wednesday - Tale of the Tape
1/15/2014 9:30:01 AM - Zacks.com


Highlights Of Recent PSivida Presentation
1/12/2014 8:15:00 AM - Seeking Alpha


Cytori Therapeutics (CYTX) Soars: Stock Adds 11.4% in Session - Tale of the Tape
1/9/2014 9:21:01 AM - Zacks.com


Achillion Pharmaceuticals (ACHN) Surges: Stock Moves 13.3% Higher - Tale of the Tape
1/9/2014 9:04:01 AM - Zacks.com


Affymetrix's Revenue Guidance Tops Ests - Analyst Blog
1/8/2014 2:50:01 PM - Zacks.com